Zydus Lifesciences Ltd
Fortune 500 2024
+ 14 More
+ 14 More
Share
Share
OVERVIEW
FINANCIALS
NEWS
About
Zydus Lifesciences is India's fourth-largest pharmaceutical company. The company was founded in 1952 by Ramanbhai B. Patel. Zydus is currently led by Chairman Pankaj Ramanbhai Patel. The company is headquartered in Ahmedabad, Gujarat. Zydus’ product portfolio includes Zydus owns several manufacturing sites and research facilities in India, including Gujarat, Maharashtra, Goa, Himachal Pradesh, Sikkim and globally in the US and Brazil. The company has over 1400 researchers across 19 sites. NCEs, vaccines, biosimilars, and niche technologies. The company has a strong presence in regulated markers like the US, Europe (France and Spain), Latin America, South Africa, and 25 other emerging markets worldwide.
Incorporation Year: 1995
Headquarters: Ahmedabad, Gujarat
Top Management: Founder- Ramanbhai B. Patel. Chairman Pankaj Ramanbhai Patel.
Industry: Pharma
Website: zyduslife.com
Featured In Fortune India Ranking
Fortune 500 India
#122(2024)
#131(2023)
#104(2022)
#99(2021)
#100(2020)
#106(2019)
#120(2018)
#133(2017)
#132(2016)
#149(2015)
#164(2014)
#174(2013)
#184(2012)
#184(2011)
#186(2010)
#122(2024)#131(2023)#104(2022)#99(2021)#100(2020)#106(2019)#120(2018)#133(2017)#132(2016)#149(2015)#164(2014)#174(2013)#184(2012)#184(2011)#186(2010)
Ranking Trend Fortune 500 India
Financial Data 2024
Revenue
20,108
(INR Cr)
Net Operating Income
19,547
(INR Cr)
Assets
24,274
(INR Cr)
Profit
3,860
(INR Cr)
Net Worth
19,830
(INR Cr)
Fortune India Coverage
Read More
Financial Data
RevenueNet Operating IncomeProfitAssetsNet Worth
| PARAMETERS | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (INR Cr) | 20108 17.0% | 17186 -4.8% | 18055 23.6% | 14605 1.0% | 14461 7.3% | 13476 9.3% | 12334 27.9% | 9644 0.9% | 9554 8.5% | 8804 19.9% | 7344 13.3% | 6484 17.9% | 5500 18.6% | 4638 22.1% | 3799 26.7% | 2998 - |
| Net Operating Income (INR Cr) | 19547 13.40% | 17237 14.08% | 15110 4.90% | 14404 1.06% | 14253 8.26% | 13166 10.59% | 11905 26.97% | 9377 -0.53% | 9427 8.96% | 8651 19.76% | 7224 13.63% | 6358 20.79% | 5263 13.66% | 4631 29.56% | 3574 24.86% | 2862 26.33% |
| Profit (INR Cr) | 3860 96.9% | 1960 -56.3% | 4487 110.3% | 2134 81.3% | 1177 -36.4% | 1849 4.1% | 1776 19.4% | 1488 -23.1% | 1934 68.1% | 1151 43.2% | 804 23.0% | 654 0.1% | 653 -8.2% | 711 40.8% | 505 66.6% | 303 - |
| Assets (INR Cr) | 24274 14.4% | 21210 -10.3% | 23658 19.0% | 19887 -0.5% | 19979 0.7% | 19838 36.3% | 14552 16.1% | 12537 48.7% | 8434 17.1% | 7204 12.3% | 6415 5.2% | 6095 19.9% | 5084 49.1% | 3411 23.7% | 2758 9.2% | 2525 - |
| Net Worth (INR Cr) | 19830 13.2% | 17516 3.0% | 17000 30.8% | 12992 25.2% | 10376 -0.1% | 10386 18.8% | 8745 25.6% | 6960 22.1% | 5699 34.1% | 4252 23.6% | 3439 21.7% | 2825 9.3% | 2586 19.1% | 2172 33.3% | 1629 31.8% | 1235 16.3% |
| Employee Cost (INR Cr) | 3138 13.5% | 2766 13.6% | 2434 6.1% | 2295 -4.2% | 2396 12.8% | 2124 14.5% | 1855 24.9% | 1485 17.5% | 1264 4.6% | 1209 12.8% | 1071 18.5% | 904 20.4% | 751 18.2% | 636 57.5% | 404 25.9% | 321 - |
| Interest Cost (INR Cr) | 81 | 130 | 127 | 159 | 342 | 194 | 91 | 45 | 53 | 68 | 90 | 169 | 183 | 70 | 82 | 98 |
| Cash & Bank Balance (INR Cr) | 1105 | 573 | 1107 | 888 | 965 | 549 | 1315 | 1544 | 639 | 670 | 549 | 584 | 467 | 295 | 251 | 252 |
| Total Debt (INR Cr) | 804 | 1195 | 4221 | 4608 | 7986 | 7899 | 5407 | 5207 | 2442 | 2651 | 2700 | 2918 | 2289 | 1092 | 1091 | 1267 |
Key Financial Ratios
Profit As % Of RevenuesRONW %Interest Cost to EBITDA %ROCE %Debt to Equity Ratio
| PARAMETERS | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profit As % Of Revenues | 19.2% | 11.4% | 24.9% | 14.6% | 8.1% | 13.7% | 14.4% | 15.4% | 20.2% | 13.1% | 10.9% | 10.1% | 11.9% | 15.3% | 13.3% | 10.1% |
| Profit As % Of Assets | 15.9% | 9.2% | 19.0% | 10.7% | 5.9% | 9.3% | 12.2% | 11.9% | 22.9% | 16.0% | 12.5% | 10.7% | 12.8% | 20.9% | 18.3% | 12.0% |
| Profit As % Of Networth | 19.5% | 11.2% | 26.4% | 16.4% | 11.3% | 17.8% | 20.3% | 21.4% | 33.9% | 27.1% | 23.4% | 23.1% | 25.2% | 32.7% | 31.0% | 24.5% |
| Interest Cost to EBITDA % | 1.5% | 4.0% | 3.8% | 5.1% | 14.1% | 6.5% | 3.2% | 2.4% | 2.3% | 3.9% | 7.6% | 15.0% | 16.9% | 6.8% | 11.9% | 19.8% |
| Debt to Equity Ratio | 0.04 | 0.07 | 0.25 | 0.35 | 0.77 | 0.76 | 0.62 | 0.75 | 0.43 | 0.62 | 0.79 | 1.03 | 0.89 | 0.50 | 0.67 | 1.03 |
| RONW | 20.6% | 14.1% | 29.8% | 20.3% | 14.2% | 19.4% | 22.3% | 23.4% | 38.6% | 30.9% | 26.7% | 25.1% | 27.7% | 37.7% | 36.2% | 25.9% |
| ROCE | 23.9% | 16.3% | 14.4% | 15.1% | 11.9% | 15.7% | 18.0% | 16.0% | 28.1% | 22.8% | 17.0% | 17.9% | 23.0% | 29.6% | 26.0% | 21.0% |